Provided by Tiger Fintech (Singapore) Pte. Ltd.

Agree

77.02
-0.1400-0.18%
Post-market: 77.020.00000.00%19:18 EDT
Volume:1.76M
Turnover:135.94M
Market Cap:8.24B
PE:43.27
High:77.42
Open:77.18
Low:76.48
Close:77.16
Loading ...

Press Release: Aadi Bioscience Relaunches as Whitehawk Therapeutics Marking Evolution into ADC Company

Dow Jones
·
11 hours ago

What Will Happen To Bitcoin Prices If Donald Trump And Vladimir Putin Agree On A Ceasefire In Ukraine?

Benzinga
·
Yesterday

Press Release: Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

Dow Jones
·
Yesterday

PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results

GlobeNewswire
·
Yesterday

Press Release: Pyxis Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Dow Jones
·
Yesterday

Energy Fuels, Chemours Agree Critical Metals Strategic Alliance

Dow Jones
·
Yesterday

Otsuka's Taiho to Buy Swiss ADC Developer Araris Biotech

MT Newswires Live
·
Yesterday

Is Pfizer (PFE) the Most Undervalued S&P 500 Stock to Buy Now?

Insider Monkey
·
Yesterday

Investigational Rinatabart Sesutecan (Rina-S®) Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

GlobeNewswire
·
Yesterday

ELAHERE® (mirvetuximab soravtansine-gynx) Shows Consistent Survival Benefit in Long-Term Analysis for Certain Ovarian Cancer Patients

PR Newswire
·
15 Mar

LUNC Community Calls for Staking Reform – Will Validators Agree?

CoinMarketCap
·
15 Mar

Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline

GlobeNewswire
·
14 Mar

IOC and Comcast NBCUniversal Agree on Groundbreaking Partnership for the New Digital Era, Including an Extension of Their Olympic Media Rights Agreement Until 2036

Business Wire
·
14 Mar

PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer

GlobeNewswire
·
13 Mar

OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference

Business Wire
·
13 Mar

Unicycive to Highlight Patient Reported Outcomes Data at Upcoming Medical Meetings Showing Oxylanthanum Carbonate Reduced Pill Burden and Improved Adherence in Treatment of Hyperphosphatemia

GlobeNewswire
·
13 Mar